Hanmi Pharmaceutical Investor

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years.
Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories.


Invests into

Headquarters: Seoul,Seoul-t'ukpyolsi,South Korea,Asia
Employee Number: 5001-10000
Industry: AI in HealthTech
Investor Type: Private Equity Funds
Founded Date: 1973-01-01
Funding Status: private